Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bentoquatam is a topical skin protectant used to prevent allergic contact dermatitis caused by exposure to urushiol, the allergenic resin found in poison ivy, poison oak, and poison sumac. It works by forming a physical barrier or coating on the skin that blocks plant oils from contacting and penetrating the skin, thereby reducing or preventing rash development. Bentoquatam does not treat existing rashes but is effective as a preventative measure when applied before exposure. The mechanism of action is primarily physical; it does not alter systemic immune responses. It is available over-the-counter as a lotion or suspension under brand names such as Ivy Block.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bentoquatam.